Michael E Prevoznik, SVP & General Counsel at Quest Diagnostics, sold DGX on Aug 28, 2026
Data as of Oct 16
▼ SELL$1.5M6,237 shares at $243.63Michael E Prevoznik SVP & General CounselDGX Quest Diagnostics Inc
- Traded
- Aug 28, 2026
- Disclosed
- Aug 31, 2026
- Filed
- 3 days after the trade
Form 4s are due within two business days.
Official filing (SEC Form 4) ↗
The price around the disclosure
DGX since disclosure
−2.2%
after the sale
Similar stocks (XLV) since disclosure
+3.6%
XLV — its sector index fund
Change in closing price from Aug 31, 2026 (the first trading day on or after disclosure) to Oct 16, 2026. Dividends excluded. Not a return anyone earned.
Our take
None of our tested rules fired on this trade.
Other trades in the same filing
- ▼ SELLMichael E Prevoznik SVP & General CounselDGX Quest Diagnostics Inc$105Kdisclosed Aug 31 · filed 3 days after the trade
- ▼ SELLMichael E Prevoznik SVP & General CounselDGX Quest Diagnostics Inc$3.9Mdisclosed Aug 31 · filed 3 days after the trade